FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ACETAMINOPHEN; DOXYLAMINE SUCCINATE; DEXTROMETHORPHAN HYDROBROMIDE | 76168-056-02 | Velocity Pharma | part341 | HUMAN OTC DRUG | OTC monograph final |
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE; DEXTROMETHORPHAN HYDROBROMIDE | 76168-057-12 | Velocity Pharma | part341 | HUMAN OTC DRUG | OTC monograph final |
CAFFEINE; PYRILAMINE MALEATE; ACETAMINOPHEN | 76168-064-03 | Velocity Pharma | part343 | HUMAN OTC DRUG | OTC monograph not final |
DIPHENHYDRAMINE HYDROCHLORIDE; ACETAMINOPHEN | 76168-119-25 | Velocity Pharma | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 76168-120-10 | Velocity Pharma LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 76281-302-24 | AptaPharma Inc. | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | 76281-304-28 | AptaPharma Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE | 76281-305-28 | AptaPharma Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE | 76281-306-25 | AptaPharma Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE | 76281-307-25 | AptaPharma Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE | 76281-501-25 | AptaPharma Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE | 76281-501-28 | AptaPharma Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DOXYLAMINE SUCCINATE; DEXTROMETHORPHAN HYDROBROMIDE | 76281-502-25 | AptaPharma Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DOXYLAMINE SUCCINATE; DEXTROMETHORPHAN HYDROBROMIDE | 76281-502-28 | AptaPharma Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE | 76281-506-28 | AptaPharma Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; GUAIFENESIN | 76281-515-25 | AptaPharma Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; GUAIFENESIN; ACETAMINOPHEN | 76281-519-24 | AptaPharma Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 76281-525-23 | AptaPharma Inc. | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 76281-525-24 | AptaPharma Inc. | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 76281-526-23 | AptaPharma Inc. | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 76281-526-24 | AptaPharma Inc. | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 76413-301-30 | Central Texas Community Health Centers | part343 | HUMAN OTC DRUG | OTC MONOGRAPH NOT FINAL |
ACETAMINOPHEN | 76413-302-12 | Central Texas Community Health Centers | ANDA072344 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 76413-343-01 | Central Texas Community Health Centers | part343 | HUMAN OTC DRUG | OTC MONOGRAPH NOT FINAL |
CODEINE PHOSPHATE; ACETAMINOPHEN | 76420-103-03 | Asclemed USA, Inc. | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 76420-103-10 | Asclemed USA, Inc. | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 76420-103-20 | Asclemed USA, Inc. | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 76420-103-30 | Asclemed USA, Inc. | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
TRAMADOL HYDROCHLORIDE; ACETAMINOPHEN | 76420-105-01 | Asclemed USA, Inc. | ANDA201952 | HUMAN PRESCRIPTION DRUG | ANDA |
TRAMADOL HYDROCHLORIDE; ACETAMINOPHEN | 76420-105-02 | Asclemed USA, Inc. | ANDA201952 | HUMAN PRESCRIPTION DRUG | ANDA |
-